Atul Peer Comparison
NSE: ATUL | BSE: 500027
₹5,156.50
As on 04-Nov-2026IST
Market cap
₹15,177 Cr
Revenue (TTM)
₹6,969 Cr
P/E Ratio
19.7
P/B Ratio
2.3
Div. Yield
0.6 %
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
15,177 | 13,996 | 6,815 | 3,386 | 1,529 |
Revenue (₹ Cr) |
6,969 | 15,312 | 1,013 | 1,270 | 277 |
Net Profit (₹ Cr) |
780.42 | 1,380.21 | 40.07 | 155.34 | 47.29 |
Net Margin (%) |
10.87 | 8.94 | 3.91 | 11.77 | 16.24 |
RoE (%) |
12.06 | 14.47 | 3.38 | 14.03 | 9.39 |
Price to Earnings |
19.66 | 10.14 | 168.60 | 21.79 | 32.34 |
Price-To-Book |
2.31 | 1.66 | 4.32 | 2.99 | 2.96 |
Income Statement (₹ Cr)
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,968.68 | 15,311.76 | 1,012.83 | 1,269.97 | 276.81 |
|
Total Income
|
7,178.55 | 15,442.13 | 1,023.72 | 1,320.22 | 291.16 |
|
Total Expenditure
|
5,800.70 | 13,799.12 | 843.47 | 1,085.58 | 196.65 |
|
EBITDA
|
1,167.98 | 1,512.64 | 169.36 | 184.39 | 80.16 |
|
Depreciation
|
315.32 | 531.15 | 31.42 | 24.94 | 29.71 |
|
EBIT
|
852.66 | 981.49 | 137.94 | 159.45 | 50.45 |
|
Interest
|
16.01 | 165.10 | 91.57 | 2.96 | 3.74 |
|
Other Income
|
209.87 | 130.37 | 10.89 | 50.25 | 14.35 |
|
Exceptional Items
|
0.00 | 56.03 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
1,046.52 | 1,002.79 | 57.26 | 206.74 | 61.06 |
|
Provision for Tax
|
266.10 | -377.42 | 17.19 | 51.40 | 13.77 |
|
Profit after Tax
|
780.42 | 1,380.21 | 40.07 | 155.34 | 47.29 |
Liabilities (₹ Cr)
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,583.07 | 8,445.29 | 1,577.51 | 1,132.76 | 516.60 |
|
Minority Interest
|
-15.39 | -2.94 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
503.18 | 2,153.21 | 943.55 | 52.31 | 99.86 |
|
Current Liabilities
|
1,246.69 | 3,706.87 | 1,484.11 | 337.04 | 68.04 |
|
Total Liabilities
|
8,031.35 | 16,276.68 | 2,901.87 | 1,444.73 | 659.94 |
Assets (₹ Cr)
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
3,730.19 | 8,347.83 | 1,734.47 | 553.77 | 520.35 |
|
Current Assets
|
4,595.14 | 5,775.77 | 2,000.94 | 900.96 | 161.56 |
|
Total Assets
|
8,031.35 | 16,276.68 | 2,901.87 | 1,444.73 | 659.94 |
|
Total Debt*
|
179.76 | 2,812.49 | 1,329.89 | 8.72 | 76.94 |
|
Net Current Assets
|
3,348.45 | 2,068.90 | 516.83 | 563.92 | 93.52 |
|
Contingent Liabilities
|
162.71 | 78.08 | 156.69 | 53.98 | 2.51 |
Cashflow (₹ Cr)
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,022.77 | 1,233.80 | -231.48 | 151.86 | 53.65 |
|
Cash Flow from Investing Activities
|
-894.55 | -1,240.63 | -410.26 | -183.82 | -95.19 |
|
Cash from Financing Activities
|
-98.46 | -306.83 | 641.71 | -27.69 | 41.54 |
|
Net Cash Inflow / Outflow
|
29.76 | -313.66 | -0.03 | -59.65 | 0.00 |
Ratios
Profitability Ratios
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
ROCE (%)
|
15.05 | 11.72 | 6.64 | 21.55 | 9.74 |
|
ROE (%)
|
12.06 | 14.47 | 3.38 | 14.03 | 9.39 |
|
ROA (%)
|
9.82 | 10.02 | 1.27 | 10.90 | 7.25 |
|
EBIT Margin (%)
|
12.24 | 6.41 | 13.62 | 12.56 | 18.23 |
|
Net Margin (%)
|
10.87 | 8.94 | 3.91 | 11.77 | 16.24 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
18.15 | 14.05 | 26.66 | 9.58 | 27.99 |
|
EBIT Growth (%)
|
36.59 | -7.44 | 30.70 | 3.90 | 6.84 |
|
Net Profit Growth (%)
|
40.86 | 93.42 | 55.43 | 2.85 | 3.93 |
|
EPS Growth (%)
|
42.35 | 64.08 | 9.59 | 2.85 | -84.43 |
|
Book Value Growth (%)
|
11.14 | 10.11 | 3.41 | 15.15 | 5.51 |
Valuation Ratios
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Price / Earnings
|
19.66 | 11.97 | 154.27 | 21.79 | 32.34 |
|
Price / Book Value
|
2.31 | 1.66 | 4.32 | 2.99 | 2.96 |
|
Dividend Yield (%)
|
0.58 | 1.25 | 0.04 | 0.67 | 0.40 |
|
EV/EBITDA
|
11.66 | 10.51 | 48.06 | 15.94 | 19.69 |
|
Market Cap (₹ Cr)
|
18,762.28 | 17,435.78 | 2,933.68 | 2,460.63 | 852.15 |
Solvency Ratios
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.02 | 0.17 | 0.54 | 0.01 | 0.10 |
|
Short term debt to equity ratio
|
0.00 | 0.13 | 0.51 | 0.00 | 0.00 |
|
Current Ratio
|
3.69 | 1.56 | 1.35 | 2.67 | 2.37 |
|
Quick Ratio
|
2.89 | 0.85 | 0.84 | 2.09 | 1.84 |
|
Interest Coverage
|
66.37 | 7.07 | 1.63 | 70.84 | 17.33 |
Operating Efficiency Ratios
| Atul | DCM Shriram | Neogen Chemicals | Grauer & Weil | Paushak | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.94 | 10.03 | 30.06 | 12.11 | 27.88 |
|
Asset Turnover
|
0.88 | 1.11 | 0.32 | 0.89 | 0.42 |
|
Receivable days
|
67.96 | 24.70 | 122.62 | 52.83 | 91.32 |
|
Inventory Days
|
43.79 | 72.95 | 185.31 | 47.31 | 48.66 |
|
Payable days
|
80.97 | 62.67 | 275.96 | 94.89 | 202.64 |
|
Cash Conversion Cycle
|
30.78 | 34.99 | 31.97 | 5.25 | -62.67 |